id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0009-0004,FDA,FDA-1999-D-0009,"Draft Guidance for Industry Disclosure of Materials Provided to Advisory Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000",Other,Guidance,2014-07-16T04:00:00Z,2014,7,2014-07-16T04:00:00Z,,2014-07-16T14:09:59Z,,0,0,09000064804a59cf
FDA-1999-D-0009-0003,FDA,FDA-1999-D-0009,"Guidance for Industry Disclosure of Materials Provided to Advisory Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000",Other,Guidance,2014-07-16T04:00:00Z,2014,7,2014-07-16T04:00:00Z,,2014-07-16T14:09:49Z,,0,0,09000064804a59ce